Loading organizations...
§ Private Profile · Pleasanton, CA, USA
Medical device company develops minimally invasive devices for valvular regurgitation, focused on tricuspid valve repair.
ConKay Medical Systems is a Bay Area, California-based medical device company developing minimally invasive catheter technologies to treat valvular regurgitation in patients with progressive heart failure. The company's annular repair system mimics open-heart surgery without requiring a chest incision, specifically targeting a global population of over 70 million patients suffering from tricuspid regurgitation. Operating with a lean team of just two employees, the enterprise recently secured an oversubscribed $1.8 million seed funding round in March 2024 to advance its device testing. This initial financing was backed by notable investors including Unorthodox Ventures, SCP Ventures LLC, and WS Investment Co. The firm is currently preparing operations to raise an $8 million to $10 million Series A round to finance first-in-human clinical trials projected for late 2025. ConKay Medical Systems was founded in 2021 by Albert Yuan.
ConKay Medical Systems has raised $1.8M across 1 funding round.
ConKay Medical Systems has raised $1.8M in total across 1 funding round.
ConKay Medical Systems has raised $1.8M in total across 1 funding round.
ConKay Medical Systems's investors include SCP Ventures, Carey Smith, WS Investment Company.
ConKay Medical Systems has raised $1.8M across 1 funding round. Most recently, it raised $1.8M Seed in March 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 18, 2024 | $1.8M Seed | — | SCP Ventures, Carey Smith, WS Investment Company | Announced |